EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy

Zhaomeng Wang iD, Yongjun Wang, Zhonggui He, Caigang Liu

Advanced Science · 2025-09 · 12 (36)

DOI: 10.1002/advs.202509890 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 21.08.2025. Verfasst von Zhaomeng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Innovative Cancer Drug Research and Engineering Center of Liaoning Province, Cancer Stem Cell and Translation Medicine Lab, S…. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Provincial Doctoral Research Start-up Fund Project, Basic Scientific Research Project of Liaoning Provincial Department of Education, Independent Investigator Project of Shengjing Hospital of China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cyclic guanosine monophosphate‐adenosine monophosphate synthase (cGAS)‐stimulator of interferon genes (STING) pathway has emerged as a promising target for cancer immunotherapy. Activation of the cGAS‐STING pathway holds significant potential to enhance antitumor immunity. However, their efficacy remains constrained by various drug delivery and pharmacological obstacles, including poor stability, limited cellular uptake, inefficient intracellular delivery, suboptimal tumor targeting, and immunotoxicity. There is a growing focus on the design and application of nanoparticulate drug delivery systems (nano‐DDSs) to improve the delivery of cGAS‐STING agonists for safe, effective, and specific targeting. This review outlines the latest advancements in cGAS‐STING agonist‐based nanotherapeutics. First, the research background of the cGAS‐STING pathway and nanotechnology is briefly outlined to emphasize the promise of STING agonist‐based nanotherapeutics in cancer immunotherapy. Second, the progress in the development of cGAS‐STING agonists and recent advancements in cGAS‐STING agonist‐based nanotherapeutics are overviewed. Moreover, the molecular mechanisms and applications of STING agonist‐based combination therapies are discussed, including synergistic strategies with chemotherapy, radiotherapy, immunotherapy (e.g., immune checkpoint blockade (ICB), indoleamine 2,3‐dioxygenase (IDO) inhibitor, cancer vaccine, adoptive cell therapy (ACT)), phototherapy, sonodynamic therapy (SDT), and targeted therapy. Finally, the challenges and future perspectives of STING agonist‐based nanotherapeutics in clinical cancer therapy are proposed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesNeoplasmsMembrane ProteinsHumansImmunotherapyAnimalsDrug Delivery SystemsCombined Modality TherapySTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

cGAS‐STING agonistscancer immunotherapycombination therapiesmechanismsnanotherapeutics

Substanzen

NucleotidyltransferasesMembrane ProteinsSTING1 protein, humanSTING ProteincGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Department of Oncology, Innovative Cancer Drug Research and Engineering Center of Liaoning Province, Cancer Stem Cell and Translation Medicine Lab, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110…
  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.

ORCID-Profile: Zhaomeng Wang

Förderung

  • Liaoning Provincial Doctoral Research Start-up Fund Project
  • Basic Scientific Research Project of Liaoning Provincial Department of Education
  • Independent Investigator Project of Shengjing Hospital of China Medical University
  • Public Health Science and Technology Project of Shenyang
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, Z., Wang, Y., He, Z., & Liu, C. (2025). Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy. Advanced Science, 12(36). https://doi.org/10.1002/advs.202509890

Vancouver

Wang Z, Wang Y, He Z, Liu C. Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy. Advanced Science. 2025;12(36). doi:10.1002/advs.202509890

BibTeX
@article{Wang2025,
  author = {Wang, Zhaomeng and Wang, Yongjun and He, Zhonggui and Liu, Caigang},
  title = {Emerging cGAS‐STING Agonist‐Based Nanotherapeutics: Mechanistic Insights and Applications in Cancer Combination Therapy},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {36},
  doi = {10.1002/advs.202509890}
}
Kostenlos starten →